Fritextsökning
Innehållstyper
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Angelica Loskog: ”Som barn var jag jättefixerad vid cancer. Där började mitt intresse”
Life Science Sweden vill veta mer om Angelica Loskog och ställer frågor om hennes liv som forskare.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Satsar på tidig forskning
Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
New management at Øresund
The Øresund University has recently appointed a new director and a new Chairman.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Positiva resultat för nytt läkemedel mot ovanlig blodsjukdom
Läkemedlet pegcetacoplan förbättrade tillståndet hos patienter vid den allvarliga och svårbehandlade sjukdomen PNH, enligt en studie.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Elyptas cancertest har fått patent i USA
Testet kan tas från urin eller blod och möjliggör en säkrare och billigare metod för upptäckt av njurcancer.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
”Kemipriset till en laddningsbar värld”
Årets pris delas av tre forskare för deras arbete med att utveckla litiumjonbatterier – en av dem är den äldsta nobelpristagaren någonsin.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
BREAKING